Krasner Alan Seth - Insider Non-Derivative Transactions at Crinetics Pharmaceuticals, Inc. (CRNX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 17, 2023, Krasner Alan Seth's relationship to Crinetics Pharmaceuticals, Inc. (CRNX) is Officer (Chief Medical Officer), and currently has 50,210 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CRNX insiders.
Data Source: SEC.
Krasner Alan Seth - Insider Non-Derivative Transactions of CRNX Common Stock
Krasner Alan Seth - Insider Non-Derivative Transactions at CRNX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 18, 2023 | Sell -- (Common Stock) | 7000 | 30 | 43210 |
| Oct 18, 2023 | M -- (Common Stock) | 7000 | 12.01 | 50210 |
| Mar 17, 2023 | F -- (Common Stock) | 1687 | 17.12 | 42301 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 19500 | 0 | 43988 |
| Nov 21, 2022 | J -- (Common Stock) | 712 | 11.02 | 24488 |
| May 21, 2022 | J -- (Common Stock) | 1215 | 11.02 | 23776 |